The results of the PDX tumor tissue model indicated that in the anlotinib group the phosphorylation levels of VEGFR2 and AKT and the protein levels of the CDK1 group were also significantly decreased, compared with the control group (Fig. 3g). This evidence concerns the gene AKT1 and neoplasm.